| Year |
Citation |
Score |
| 2022 |
Zuba V, Furon J, Bellemain-Sagnard M, de Lazarrondo SM, Lebouvier L, Rubio M, Hommet Y, Gauberti M, Vivien D, Ali C. Correction to: The choroid plexus: A door between the blood and the brain for tissue-type plasminogen activator. Fluids and Barriers of the Cns. 19: 83. PMID 36320083 DOI: 10.1186/s12987-022-00383-3 |
0.5 |
|
| 2022 |
Zuba V, Furon J, Bellemain-Sagnard M, Martinez de Lizarrondo S, Lebouvier L, Rubio M, Hommet Y, Gauberti M, Vivien D, Ali C. The choroid plexus: a door between the blood and the brain for tissue-type plasminogen activator. Fluids and Barriers of the Cns. 19: 80. PMID 36243724 DOI: 10.1186/s12987-022-00378-0 |
0.535 |
|
| 2022 |
Lépine M, Douceau S, Devienne G, Prunotto P, Lenoir S, Regnauld C, Pouettre E, Piquet J, Lebouvier L, Hommet Y, Maubert E, Agin V, Lambolez B, Cauli B, Ali C, et al. Parvalbumin interneuron-derived tissue-type plasminogen activator shapes perineuronal net structure. Bmc Biology. 20: 218. PMID 36199089 DOI: 10.1186/s12915-022-01419-8 |
0.496 |
|
| 2022 |
Drieu A, Lanquetin A, Prunotto P, Gulhan Z, Pédron S, Vegliante G, Tolomeo D, Serrière S, Vercouillie J, Galineau L, Tauber C, Kuhnast B, Rubio M, Zanier ER, Levard D, ... ... Ali C, et al. Persistent neuroinflammation and behavioural deficits after single mild traumatic brain injury. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X221119288. PMID 35945692 DOI: 10.1177/0271678X221119288 |
0.462 |
|
| 2022 |
Tomadesso C, de Lizarrondo SM, Ali C, Landeau B, Mézenge F, Perrotin A, de La Sayette V, Vivien D, Chételat G. Plasma Levels of Tissue-Type Plasminogen Activator (tPA) in Normal Aging and Alzheimer's Disease: Links With Cognition, Brain Structure, Brain Function and Amyloid Burden. Frontiers in Aging Neuroscience. 14: 871214. PMID 35747448 DOI: 10.3389/fnagi.2022.871214 |
0.453 |
|
| 2022 |
Metayer T, Orset C, Ali C, Furon J, Szabla N, Emery E, Vivien D, Gaberel T. Bumetanide lowers acute hydrocephalus in a rat model of subarachnoid hemorrhage. Acta Neurochirurgica. PMID 35094147 DOI: 10.1007/s00701-021-05088-4 |
0.447 |
|
| 2021 |
Hedou E, Douceau S, Chevilley A, Varangot A, Thiebaut AM, Triniac H, Bardou I, Ali C, Maillasson M, Crepaldi T, Comoglio P, Lemarchand E, Agin V, Roussel BD, Vivien D. Two-Chains Tissue Plasminogen Activator Unifies Met and NMDA Receptor Signalling to Control Neuronal Survival. International Journal of Molecular Sciences. 22. PMID 34948279 DOI: 10.3390/ijms222413483 |
0.556 |
|
| 2021 |
Goursaud S, Martinez de Lizarrondo S, Grolleau F, Chagnot A, Agin V, Maubert E, Gauberti M, Vivien D, Ali C, Gakuba C. Delayed Cerebral Ischemia After Subarachnoid Hemorrhage: Is There a Relevant Experimental Model? A Systematic Review of Preclinical Literature. Frontiers in Cardiovascular Medicine. 8: 752769. PMID 34869659 DOI: 10.3389/fcvm.2021.752769 |
0.463 |
|
| 2021 |
Garnier E, Levard D, Ali C, Buendia I, Hommet Y, Gauberti M, Crepaldi T, Comoglio P, Rubio M, Vivien D, Docagne F, Martinez de Lizarrondo S. Factor XII protects neurons from apoptosis by epidermal and hepatocyte growth factor receptor-dependent mechanisms. Journal of Thrombosis and Haemostasis : Jth. PMID 34060720 DOI: 10.1111/jth.15414 |
0.526 |
|
| 2021 |
Salaün JP, Poirel N, Dahmani S, Chagnot A, Gakuba C, Ali C, Gérard JL, Hanouz JL, Orliaguet G, Vivien D. Preventing the long-term effects of general anesthesia on the developing brain: how translational research can contribute. Neuroscience. PMID 33675916 DOI: 10.1016/j.neuroscience.2021.02.029 |
0.418 |
|
| 2019 |
Vegliante G, Tolomeo D, Drieu A, Rubio M, Micotti E, Moro F, Vivien D, Forloni G, Ali C, Zanier ER. Longitudinal Molecular Magnetic Resonance Imaging of Endothelial Activation after Severe Traumatic Brain Injury. Journal of Clinical Medicine. 8. PMID 31366109 DOI: 10.3390/jcm8081134 |
0.456 |
|
| 2018 |
Thiebaut AM, Gauberti M, Ali C, Martinez De Lizarrondo S, Vivien D, Yepes M, Roussel BD. The role of plasminogen activators in stroke treatment: fibrinolysis and beyond. The Lancet. Neurology. 17: 1121-1132. PMID 30507392 DOI: 10.1016/S1474-4422(18)30323-5 |
0.568 |
|
| 2017 |
Pruvost M, Lépine M, Leonetti C, Etard O, Naveau M, Agin V, Docagne F, Maubert E, Ali C, Emery E, Vivien D. ADAMTS-4 in oligodendrocytes contributes to myelination with an impact on motor function. Glia. PMID 28850711 DOI: 10.1002/Glia.23207 |
0.405 |
|
| 2017 |
Louessard M, Bardou I, Lemarchand E, Thiebaut AM, Parcq J, Leprince J, Terrisse A, Carraro V, Fafournoux P, Bruhat A, Orset C, Vivien D, Ali C, Roussel BD. Activation of cell surface GRP78 decreases endoplasmic reticulum stress and neuronal death. Cell Death and Differentiation. PMID 28644439 DOI: 10.1038/cdd.2017.35 |
0.509 |
|
| 2017 |
Martinez de Lizarrondo S, Gakuba C, Herbig BA, Repessé Y, Ali C, Denis CV, Lenting P, Touzé E, Diamond SL, Vivien D, Gauberti M. Potent Thrombolytic Effect of N-Acetylcysteine on Arterial Thrombi. Circulation. PMID 28487393 DOI: 10.1161/Circulationaha.117.027290 |
0.514 |
|
| 2017 |
Quenault A, Martinez de Lizarrondo S, Etard O, Gauberti M, Orset C, Haelewyn B, Segal HC, Rothwell PM, Vivien D, Touzé E, Ali C. Molecular magnetic resonance imaging discloses endothelial activation after transient ischaemic attack. Brain : a Journal of Neurology. 140: 146-157. PMID 28031221 DOI: 10.1093/Brain/Aww260 |
0.476 |
|
| 2016 |
Lesept F, Chevilley A, Jezequel J, Ladépêche L, Macrez R, Aimable M, Lenoir S, Bertrand T, Rubrecht L, Galea P, Lebouvier L, Petersen KU, Hommet Y, Maubert E, Ali C, et al. Tissue-type plasminogen activator controls neuronal death by raising surface dynamics of extrasynaptic NMDA receptors. Cell Death & Disease. 7: e2466. PMID 27831563 DOI: 10.1038/cddis.2016.279 |
0.531 |
|
| 2015 |
Chevilley A, Lesept F, Lenoir S, Ali C, Parcq J, Vivien D. Impacts of tissue-type plasminogen activator (tPA) on neuronal survival. Frontiers in Cellular Neuroscience. 9: 415. PMID 26528141 DOI: 10.3389/fncel.2015.00415 |
0.575 |
|
| 2015 |
Mehra A, Ali C, Parcq J, Vivien D, Docagne F. The plasminogen activation system in neuroinflammation. Biochimica Et Biophysica Acta. PMID 26493446 DOI: 10.1016/j.bbadis.2015.10.011 |
0.526 |
|
| 2015 |
Lemarchand E, Gauberti M, Martinez de Lizarrondo S, Villain H, Repessé Y, Montagne A, Vivien D, Ali C, Rubio M. Impact of alcohol consumption on the outcome of ischemic stroke and thrombolysis: role of the hepatic clearance of tissue-type plasminogen activator. Stroke; a Journal of Cerebral Circulation. 46: 1641-50. PMID 25922513 DOI: 10.1161/STROKEAHA.114.007143 |
0.54 |
|
| 2015 |
Merino-Zamorano C, Hernández-Guillamon M, Jullienne A, Le Béhot A, Bardou I, Parés M, Fernández-Cadenas I, Giralt D, Carrera C, Ribó M, Vivien D, Ali C, Rosell A, Montaner J. NURR1 involvement in recombinant tissue-type plasminogen activator treatment complications after ischemic stroke. Stroke; a Journal of Cerebral Circulation. 46: 477-84. PMID 25503547 DOI: 10.1161/STROKEAHA.114.006826 |
0.766 |
|
| 2015 |
Docagne F, Parcq J, Lijnen R, Ali C, Vivien D. Understanding the functions of endogenous and exogenous tissue-type plasminogen activator during stroke. Stroke; a Journal of Cerebral Circulation. 46: 314-20. PMID 25395410 DOI: 10.1161/STROKEAHA.114.006698 |
0.611 |
|
| 2014 |
Lemarchant S, Pruvost M, Hébert M, Gauberti M, Hommet Y, Briens A, Maubert E, Gueye Y, Féron F, Petite D, Mersel M, do Rego JC, Vaudry H, Koistinaho J, Ali C, et al. tPA promotes ADAMTS-4-induced CSPG degradation, thereby enhancing neuroplasticity following spinal cord injury. Neurobiology of Disease. 66: 28-42. PMID 24576594 DOI: 10.1016/J.Nbd.2014.02.005 |
0.465 |
|
| 2013 |
Rosell A, Agin V, Rahman M, Morancho A, Ali C, Koistinaho J, Wang X, Vivien D, Schwaninger M, Montaner J. Distal occlusion of the middle cerebral artery in mice: are we ready to assess long-term functional outcome? Translational Stroke Research. 4: 297-307. PMID 24323300 DOI: 10.1007/S12975-012-0234-1 |
0.452 |
|
| 2013 |
Gaberel T, Macrez R, Gauberti M, Montagne A, Hebert M, Petersen KU, Touze E, Agin V, Emery E, Ali C, Vivien D. Immunotherapy blocking the tissue plasminogen activator-dependent activation of N-methyl-D-aspartate glutamate receptors improves hemorrhagic stroke outcome. Neuropharmacology. 67: 267-71. PMID 23219658 DOI: 10.1016/j.neuropharm.2012.11.023 |
0.638 |
|
| 2013 |
Henry VJ, Lecointre M, Laudenbach V, Ali C, Macrez R, Jullienne A, Berezowski V, Carmeliet P, Vivien D, Marret S, Gonzalez BJ, Leroux P. High t-PA release by neonate brain microvascular endothelial cells under glutamate exposure affects neuronal fate. Neurobiology of Disease. 50: 201-8. PMID 23103420 DOI: 10.1016/j.nbd.2012.10.020 |
0.754 |
|
| 2012 |
Kaindl AM, Degos V, Peineau S, Gouadon E, Chhor V, Loron G, Le Charpentier T, Josserand J, Ali C, Vivien D, Collingridge GL, Lombet A, Issa L, Rene F, Loeffler JP, et al. Activation of microglial N-methyl-D-aspartate receptors triggers inflammation and neuronal cell death in the developing and mature brain. Annals of Neurology. 72: 536-49. PMID 23109148 DOI: 10.1002/ana.23626 |
0.585 |
|
| 2012 |
Obiang P, Macrez R, Jullienne A, Bertrand T, Lesept F, Ali C, Maubert E, Vivien D, Agin V. GluN2D subunit-containing NMDA receptors control tissue plasminogen activator-mediated spatial memory. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 12726-34. PMID 22972996 DOI: 10.1523/JNEUROSCI.6202-11.2012 |
0.753 |
|
| 2012 |
Vivien D, Ali C. Traumatic brain injury: tissue-type plasminogen activator--harmful or beneficial? Nature Reviews. Neurology. 8: 538-9. PMID 22964508 DOI: 10.1038/nrneurol.2012.192 |
0.55 |
|
| 2012 |
Montagne A, Hébert M, Jullienne A, Lesept F, Le Béhot A, Louessard M, Gauberti M, Orset C, Ali C, Agin V, Maubert E, Vivien D. Memantine improves safety of thrombolysis for stroke. Stroke; a Journal of Cerebral Circulation. 43: 2774-81. PMID 22879098 DOI: 10.1161/STROKEAHA.112.669374 |
0.78 |
|
| 2012 |
Lemarchant S, Docagne F, Emery E, Vivien D, Ali C, Rubio M. tPA in the injured central nervous system: different scenarios starring the same actor? Neuropharmacology. 62: 749-56. PMID 22079561 DOI: 10.1016/j.neuropharm.2011.10.020 |
0.567 |
|
| 2011 |
Jullienne A, Montagne A, Orset C, Lesept F, Jane DE, Monaghan DT, Maubert E, Vivien D, Ali C. Selective inhibition of GluN2D-containing N-methyl-D-aspartate receptors prevents tissue plasminogen activator-promoted neurotoxicity both in vitro and in vivo. Molecular Neurodegeneration. 6: 68. PMID 21975018 DOI: 10.1186/1750-1326-6-68 |
0.782 |
|
| 2011 |
Raoult E, Roussel BD, Bénard M, Lefebvre T, Ravni A, Ali C, Vivien D, Komuro H, Fournier A, Vaudry H, Vaudry D, Galas L. Pituitary adenylate cyclase-activating polypeptide (PACAP) stimulates the expression and the release of tissue plasminogen activator (tPA) in neuronal cells: involvement of tPA in the neuroprotective effect of PACAP. Journal of Neurochemistry. 119: 920-31. PMID 21919910 DOI: 10.1111/J.1471-4159.2011.07486.X |
0.523 |
|
| 2011 |
Rubio M, Villain H, Docagne F, Roussel BD, Ramos JA, Vivien D, Fernandez-Ruiz J, Ali C. Pharmacological activation/inhibition of the cannabinoid system affects alcohol withdrawal-induced neuronal hypersensitivity to excitotoxic insults. Plos One. 6: e23690. PMID 21886913 DOI: 10.1371/journal.pone.0023690 |
0.503 |
|
| 2011 |
Meissirel C, Ruiz de Almodovar C, Knevels E, Coulon C, Chounlamountri N, Segura I, de Rossi P, Vinckier S, Anthonis K, Deléglise B, de Mol M, Ali C, Dassonville K, Loyens E, Honnorat J, et al. VEGF modulates NMDA receptors activity in cerebellar granule cells through Src-family kinases before synapse formation. Proceedings of the National Academy of Sciences of the United States of America. 108: 13782-7. PMID 21804034 DOI: 10.1073/Pnas.1100341108 |
0.476 |
|
| 2011 |
Macrez R, Obiang P, Gauberti M, Roussel B, Baron A, Parcq J, Cassé F, Hommet Y, Orset C, Agin V, Bezin L, Berrocoso TG, Petersen KU, Montaner J, Maubert E, ... ... Ali C, et al. Antibodies preventing the interaction of tissue-type plasminogen activator with N-methyl-D-aspartate receptors reduce stroke damages and extend the therapeutic window of thrombolysis. Stroke; a Journal of Cerebral Circulation. 42: 2315-22. PMID 21680906 DOI: 10.1161/STROKEAHA.110.606293 |
0.617 |
|
| 2011 |
Roussel BD, Mysiorek C, Rouhiainen A, Jullienne A, Parcq J, Hommet Y, Culot M, Berezowski V, Cecchelli R, Rauvala H, Vivien D, Ali C. HMGB-1 promotes fibrinolysis and reduces neurotoxicity mediated by tissue plasminogen activator. Journal of Cell Science. 124: 2070-6. PMID 21610098 DOI: 10.1242/jcs.084392 |
0.796 |
|
| 2011 |
Correa F, Gauberti M, Parcq J, Macrez R, Hommet Y, Obiang P, Hernangómez M, Montagne A, Liot G, Guaza C, Maubert E, Ali C, Vivien D, Docagne F. Tissue plasminogen activator prevents white matter damage following stroke. The Journal of Experimental Medicine. 208: 1229-42. PMID 21576385 DOI: 10.1084/jem.20101880 |
0.606 |
|
| 2011 |
Macrez R, Ali C, Toutirais O, Le Mauff B, Defer G, Dirnagl U, Vivien D. Stroke and the immune system: from pathophysiology to new therapeutic strategies. The Lancet. Neurology. 10: 471-80. PMID 21511199 DOI: 10.1016/S1474-4422(11)70066-7 |
0.526 |
|
| 2010 |
Macrez R, Bezin L, Le Mauff B, Ali C, Vivien D. Functional occurrence of the interaction of tissue plasminogen activator with the NR1 Subunit of N-methyl-D-aspartate receptors during stroke. Stroke; a Journal of Cerebral Circulation. 41: 2950-5. PMID 20966414 DOI: 10.1161/STROKEAHA.110.592360 |
0.621 |
|
| 2009 |
Roussel BD, Hommet Y, Macrez R, Schulz T, Petersen KU, Berezowski V, Cecchelli R, Ali C, Vivien D. PPACK-Desmodus rotundus salivary plasminogen activator (cDSPAalpha1) prevents the passage of tissue-type plasminogen activator (rt-PA) across the blood-brain barrier and neurotoxicity. Thrombosis and Haemostasis. 102: 606-8. PMID 19718485 DOI: 10.1160/TH09-02-0114 |
0.524 |
|
| 2009 |
Roussel BD, Macrez R, Jullienne A, Agin V, Maubert E, Dauphinot L, Potier MC, Plawinski L, Castel H, Hommet Y, Munuera J, Montaner J, Yepes M, Ali C, Vivien D. Age and albumin D site-binding protein control tissue plasminogen activator levels: neurotoxic impact. Brain : a Journal of Neurology. 132: 2219-30. PMID 19574439 DOI: 10.1093/brain/awp162 |
0.773 |
|
| 2009 |
Legros H, Launay S, Roussel BD, Marcou-Labarre A, Calbo S, Catteau J, Leroux P, Boyer O, Ali C, Marret S, Vivien D, Laudenbach V. Newborn- and adult-derived brain microvascular endothelial cells show age-related differences in phenotype and glutamate-evoked protease release. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 29: 1146-58. PMID 19367295 DOI: 10.1038/Jcbfm.2009.39 |
0.501 |
|
| 2009 |
Yepes M, Roussel BD, Ali C, Vivien D. Tissue-type plasminogen activator in the ischemic brain: more than a thrombolytic. Trends in Neurosciences. 32: 48-55. PMID 18963068 DOI: 10.1016/j.tins.2008.09.006 |
0.599 |
|
| 2008 |
Lebeurrier N, Launay S, Macrez R, Maubert E, Legros H, Leclerc A, Jamin SP, Picard JY, Marret S, Laudenbach V, Berger P, Sonderegger P, Ali C, di Clemente N, Vivien D. Anti-Mullerian-hormone-dependent regulation of the brain serine-protease inhibitor neuroserpin. Journal of Cell Science. 121: 3357-65. PMID 18796535 DOI: 10.1242/Jcs.031872 |
0.571 |
|
| 2008 |
Lopez-Atalaya JP, Roussel BD, Levrat D, Parcq J, Nicole O, Hommet Y, Benchenane K, Castel H, Leprince J, To Van D, Bureau R, Rault S, Vaudry H, Petersen KU, Santos JS, ... Ali C, et al. Toward safer thrombolytic agents in stroke: molecular requirements for NMDA receptor-mediated neurotoxicity. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 28: 1212-21. PMID 18334994 DOI: 10.1038/jcbfm.2008.14 |
0.56 |
|
| 2007 |
Young AR, Ali C, Duretête A, Vivien D. Neuroprotection and stroke: time for a compromise. Journal of Neurochemistry. 103: 1302-9. PMID 17727635 DOI: 10.1111/j.1471-4159.2007.04866.x |
0.511 |
|
| 2007 |
López-Atalaya JP, Roussel BD, Ali C, Maubert E, Petersen KU, Berezowski V, Cecchelli R, Orset C, Vivien D. Recombinant Desmodus rotundus salivary plasminogen activator crosses the blood-brain barrier through a low-density lipoprotein receptor-related protein-dependent mechanism without exerting neurotoxic effects. Stroke; a Journal of Cerebral Circulation. 38: 1036-43. PMID 17325305 DOI: 10.1161/01.STR.0000258100.04923.84 |
0.596 |
|
| 2007 |
Benchenane K, Castel H, Boulouard M, Bluthé R, Fernandez-Monreal M, Roussel BD, Lopez-Atalaya JP, Butt-Gueulle S, Agin V, Maubert E, Dantzer R, Touzani O, Dauphin F, Vivien D, Ali C. Anti-NR1 N-terminal-domain vaccination unmasks the crucial action of tPA on NMDA-receptor-mediated toxicity and spatial memory. Journal of Cell Science. 120: 578-85. PMID 17244650 DOI: 10.1242/Jcs.03354 |
0.563 |
|
| 2007 |
Docagne F, Muñetón V, Clemente D, Ali C, LorÃa F, Correa F, Hernangómez M, Mestre L, Vivien D, Guaza C. Excitotoxicity in a chronic model of multiple sclerosis: Neuroprotective effects of cannabinoids through CB1 and CB2 receptor activation. Molecular and Cellular Neurosciences. 34: 551-61. PMID 17229577 DOI: 10.1016/j.mcn.2006.12.005 |
0.421 |
|
| 2006 |
Liot G, Roussel BD, Lebeurrier N, Benchenane K, López-Atalaya JP, Vivien D, Ali C. Tissue-type plasminogen activator rescues neurones from serum deprivation-induced apoptosis through a mechanism independent of its proteolytic activity. Journal of Neurochemistry. 98: 1458-64. PMID 16800849 DOI: 10.1111/j.1471-4159.2006.03982.x |
0.566 |
|
| 2006 |
Vivien D, Ali C. Transforming growth factor-beta signalling in brain disorders. Cytokine & Growth Factor Reviews. 17: 121-8. PMID 16271500 DOI: 10.1016/j.cytogfr.2005.09.011 |
0.468 |
|
| 2005 |
Lesné S, Ali C, Gabriel C, Croci N, MacKenzie ET, Glabe CG, Plotkine M, Marchand-Verrecchia C, Vivien D, Buisson A. NMDA receptor activation inhibits alpha-secretase and promotes neuronal amyloid-beta production. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 9367-77. PMID 16221845 DOI: 10.1523/Jneurosci.0849-05.2005 |
0.511 |
|
| 2005 |
Lebeurrier N, Liot G, Lopez-Atalaya JP, Orset C, Fernandez-Monreal M, Sonderegger P, Ali C, Vivien D. The brain-specific tissue-type plasminogen activator inhibitor, neuroserpin, protects neurons against excitotoxicity both in vitro and in vivo. Molecular and Cellular Neurosciences. 30: 552-8. PMID 16209928 DOI: 10.1016/J.Mcn.2005.09.005 |
0.637 |
|
| 2005 |
Benchenane K, Berezowski V, Ali C, Fernández-Monreal M, López-Atalaya JP, Brillault J, Chuquet J, Nouvelot A, MacKenzie ET, Bu G, Cecchelli R, Touzani O, Vivien D. Tissue-type plasminogen activator crosses the intact blood-brain barrier by low-density lipoprotein receptor-related protein-mediated transcytosis. Circulation. 111: 2241-9. PMID 15851587 DOI: 10.1161/01.CIR.0000163542.48611.A2 |
0.567 |
|
| 2005 |
Benchenane K, Berezowski V, Fernández-Monreal M, Brillault J, Valable S, Dehouck MP, Cecchelli R, Vivien D, Touzani O, Ali C. Oxygen glucose deprivation switches the transport of tPA across the blood-brain barrier from an LRP-dependent to an increased LRP-independent process. Stroke; a Journal of Cerebral Circulation. 36: 1065-70. PMID 15817895 DOI: 10.1161/01.STR.0000163050.39122.4f |
0.556 |
|
| 2004 |
Liot G, Benchenane K, Léveillé F, López-Atalaya JP, Fernández-Monreal M, Ruocco A, Mackenzie ET, Buisson A, Ali C, Vivien D. 2,7-Bis-(4-amidinobenzylidene)-cycloheptan-1-one dihydrochloride, tPA stop, prevents tPA-enhanced excitotoxicity both in vitro and in vivo. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 24: 1153-9. PMID 15529015 DOI: 10.1097/01.WCB.0000134476.93809.75 |
0.623 |
|
| 2004 |
Fernández-Monreal M, López-Atalaya JP, Benchenane K, Cacquevel M, Dulin F, Le Caer JP, Rossier J, Jarrige AC, Mackenzie ET, Colloc'h N, Ali C, Vivien D. Arginine 260 of the amino-terminal domain of NR1 subunit is critical for tissue-type plasminogen activator-mediated enhancement of N-methyl-D-aspartate receptor signaling. The Journal of Biological Chemistry. 279: 50850-6. PMID 15448144 DOI: 10.1074/jbc.M407069200 |
0.558 |
|
| 2004 |
Lebeurrier N, Vivien D, Ali C. The complexity of tissue-type plasminogen activator: can serine protease inhibitors help in stroke management? Expert Opinion On Therapeutic Targets. 8: 309-20. PMID 15268626 DOI: 10.1517/14728222.8.4.309 |
0.578 |
|
| 2004 |
Liot G, Gabriel C, Cacquevel M, Ali C, MacKenzie ET, Buisson A, Vivien D. Neurotrophin-3-induced PI-3 kinase/Akt signaling rescues cortical neurons from apoptosis. Experimental Neurology. 187: 38-46. PMID 15081586 DOI: 10.1016/j.expneurol.2004.01.002 |
0.475 |
|
| 2003 |
Buisson A, Lesne S, Docagne F, Ali C, Nicole O, MacKenzie ET, Vivien D. Transforming growth factor-beta and ischemic brain injury. Cellular and Molecular Neurobiology. 23: 539-50. PMID 14514014 DOI: 10.1023/A:1025072013107 |
0.541 |
|
| 2003 |
Docagne F, Ali C, Lesne S, Nicole O, MacKenzie ET, Buisson A, Vivien D. [Does transforming growth factor-beta (TGF-beta) act as a neuroprotective agent in cerebral ischemia?]. Journal De La Sociã©Tã© De Biologie. 197: 145-50. PMID 12910629 |
0.525 |
|
| 2003 |
Gabriel C, Ali C, Lesné S, Fernández-Monreal M, Docagne F, Plawinski L, MacKenzie ET, Buisson A, Vivien D. Transforming growth factor alpha-induced expression of type 1 plasminogen activator inhibitor in astrocytes rescues neurons from excitotoxicity. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 17: 277-9. PMID 12490542 DOI: 10.1096/Fj.02-0403Fje |
0.543 |
|
| 2002 |
Docagne F, Nicole O, Gabriel C, Fernández-Monreal M, Lesné S, Ali C, Plawinski L, Carmeliet P, MacKenzie ET, Buisson A, Vivien D. Smad3-dependent induction of plasminogen activator inhibitor-1 in astrocytes mediates neuroprotective activity of transforming growth factor-beta 1 against NMDA-induced necrosis. Molecular and Cellular Neurosciences. 21: 634-44. PMID 12504596 DOI: 10.1006/Mcne.2002.1206 |
0.578 |
|
| Show low-probability matches. |